Characterization of the p53 cistrome--DNA binding cooperativity dissects p53's tumor suppressor functions.
Name:
schlereth et al_final.pdf
Size:
2.783Mb
Format:
PDF
Description:
Open Access publication
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Schlereth, KatharinaHeyl, Charlotte
Krampitz, Anna-Maria
Mernberger, Marco
Finkernagel, Florian
Scharfe, Maren
Jarek, Michael
Leich, Ellen
Rosenwald, Andreas
Stiewe, Thorsten
Issue Date
2013-08
Metadata
Show full item recordAbstract
p53 protects us from cancer by transcriptionally regulating tumor suppressive programs designed to either prevent the development or clonal expansion of malignant cells. How p53 selects target genes in the genome in a context- and tissue-specific manner remains largely obscure. There is growing evidence that the ability of p53 to bind DNA in a cooperative manner prominently influences target gene selection with activation of the apoptosis program being completely dependent on DNA binding cooperativity. Here, we used ChIP-seq to comprehensively profile the cistrome of p53 mutants with reduced or increased cooperativity. The analysis highlighted a particular relevance of cooperativity for extending the p53 cistrome to non-canonical binding sequences characterized by deletions, spacer insertions and base mismatches. Furthermore, it revealed a striking functional separation of the cistrome on the basis of cooperativity; with low cooperativity genes being significantly enriched for cell cycle and high cooperativity genes for apoptotic functions. Importantly, expression of high but not low cooperativity genes was correlated with superior survival in breast cancer patients. Interestingly, in contrast to most p53-activated genes, p53-repressed genes did not commonly contain p53 binding elements. Nevertheless, both the degree of gene activation and repression were cooperativity-dependent, suggesting that p53-mediated gene repression is largely indirect and mediated by cooperativity-dependently transactivated gene products such as CDKN1A, E2F7 and non-coding RNAs. Since both activation of apoptosis genes with non-canonical response elements and repression of pro-survival genes are crucial for p53's apoptotic activity, the cistrome analysis comprehensively explains why p53-induced apoptosis, but not cell cycle arrest, strongly depends on the intermolecular cooperation of p53 molecules as a possible safeguard mechanism protecting from accidental cell killing.Citation
Characterization of the p53 cistrome--DNA binding cooperativity dissects p53's tumor suppressor functions. 2013, 9 (8):e1003726 PLoS Genet.Affiliation
Molecular Oncology, Philipps-University, Marburg, Germany.Journal
PLoS geneticsPubMed ID
23966881Type
ArticleLanguage
enISSN
1553-7404ae974a485f413a2113503eed53cd6c53
10.1371/journal.pgen.1003726
Scopus Count
The following license files are associated with this item:
Related articles
- Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
- Authors: Fischer M, Quaas M, Nickel A, Engeland K
- Issue date: 2015 Dec 8
- E2F7, a novel target, is up-regulated by p53 and mediates DNA damage-dependent transcriptional repression.
- Authors: Carvajal LA, Hamard PJ, Tonnessen C, Manfredi JJ
- Issue date: 2012 Jul 15
- DNA binding cooperativity of p53 modulates the decision between cell-cycle arrest and apoptosis.
- Authors: Schlereth K, Beinoraviciute-Kellner R, Zeitlinger MK, Bretz AC, Sauer M, Charles JP, Vogiatzi F, Leich E, Samans B, Eilers M, Kisker C, Rosenwald A, Stiewe T
- Issue date: 2010 May 14
- Cell cycle regulation: p53-p21-RB signaling.
- Authors: Engeland K
- Issue date: 2022 May
- Che-1 modulates the decision between cell cycle arrest and apoptosis by its binding to p53.
- Authors: Desantis A, Bruno T, Catena V, De Nicola F, Goeman F, Iezzi S, Sorino C, Gentileschi MP, Germoni S, Monteleone V, Pellegrino M, Kann M, De Meo PD, Pallocca M, Höpker K, Moretti F, Mattei E, Reinhardt HC, Floridi A, Passananti C, Benzing T, Blandino G, Fanciulli M
- Issue date: 2015 May 21